Position in ATAI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$177,000
New position
Shares Held
50,000
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MYDA Advisors LLC holds $37,336,697 across 11 Biotechnology names. ATAI ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
1,225,000 | $10,363,500 | |
| 2 | MANE |
Veradermics, Inc
|
120,000 | $7,578,000 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
240,000 | $5,654,400 | |
| 4 | EYPT |
EyePoint, Inc.
|
330,000 | $4,253,700 | |
| 5 | BNTC |
Benitec Biopharma Inc.
|
225,000 | $2,396,250 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
40,000 | $2,108,800 | |
| 7 | CELC |
Celcuity Inc.
|
15,000 | $1,712,100 | |
| 8 | IMTX |
Immatics N.V.
|
120,000 | $1,180,800 |
All Filings in ATAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $177,000 | 50,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||